Status:
UNKNOWN
Immune Cells Phenotypes During COVID-19
Lead Sponsor:
Institut Hospitalo-Universitaire Méditerranée Infection
Collaborating Sponsors:
Hôpital Européen Marseille
Assistance Publique Hopitaux De Marseille
Conditions:
Sars-CoV2
Innate Immunity
Eligibility:
All Genders
18+ years
Brief Summary
The ongoing pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) has infected more than one hundred twenty million peoples worldwide one year after its onset with a case...
Eligibility Criteria
Inclusion
- Age \> 18 y
- Laboratory confirmed SARS CoV-2 infection (positive RT-PCR).
- Ground-glass opacity on chest computed-tomography
- Time from hospital admission to inclusion \< or equal to 72 h
Exclusion
- Pregnant
- Under legal restriction
Key Trial Info
Start Date :
March 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04816760
Start Date
March 25 2020
End Date
December 1 2021
Last Update
March 25 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Europeen Marseille
Marseille, France, 13003
2
Hopital Nord
Marseille, France, 13015